Mechanisms of resistance of malaria parasites to antifolates

A Gregson, CV Plowe - Pharmacological reviews, 2005 - ASPET
Antifolate antimalarial drugs interfere with folate metabolism, a pathway essential to malaria
parasite survival. This class of drugs includes effective causal prophylactic and therapeutic …

The past, present and future of antifolates in the treatment of Plasmodium falciparum infection

A Nzila - Journal of Antimicrobial Chemotherapy, 2006 - academic.oup.com
Chemotherapy remains the most important means of controlling malaria, one of the
deadliest infectious parasitic diseases in the world. Antimalarial antifolates have been …

Comparative folate metabolism in humans and malaria parasites (part I): pointers for malaria treatment from cancer chemotherapy

A Nzila, SA Ward, K Marsh, PFG Sims, JE Hyde - Trends in parasitology, 2005 - cell.com
New inhibitors are urgently needed to overcome the burgeoning problem of drug resistance
in the treatment of Plasmodium falciparum infection. Targeting the folate pathway has …

Inhibitors of de novo folate enzymes in Plasmodium falciparum

A Nzila - Drug discovery today, 2006 - Elsevier
Antifolates, inhibitors of folate synthesis or folate conversion, are used for malaria treatment.
They are developed as synergistic combinations of inhibitors of dihydrofolate reductase …

The rise and fall of the antimalarial Lapdap: a lesson in pharmacogenetics

L Luzzatto - The Lancet, 2010 - thelancet.com
The spread of chloroquine-resistant Plasmodium falciparum in Africa has been a strong
stimulus to the development of new antimalarial drugs. Although artemisinin and related …

Drug repurposing for the treatment of staphylococcal infections

S Thangamani, H Mohammad… - Current …, 2015 - ingentaconnect.com
The development and approval of new antimicrobials capable of being used to treat
infections caused by multidrug-resistant pathogens has not kept pace with the rapid …

4-aminoquinoline based molecular hybrids as antimalarials: an overview

S Manohar, M Tripathi… - Current topics in medicinal …, 2014 - ingentaconnect.com
In recent times, the novel concept of generating hybrid molecules by pharmacophoric
hybridisation approach is fast becoming an alternative to other existing strategies of drug …

Dihydrofolate Reductase Is a Valid Target for Antifungal Development in the Human Pathogen Candida albicans

C DeJarnette, A Luna-Tapia, LR Estredge, GE Palmer - Msphere, 2020 - Am Soc Microbiol
While the folate biosynthetic pathway has provided a rich source of antibacterial,
antiprotozoal, and anticancer therapies, it has not yet been exploited to develop uniquely …

[HTML][HTML] Randomized trial of artesunate+ amodiaquine, sulfadoxine-pyrimethamine+ amodiaquine, chlorproguanal-dapsone and SP for malaria in pregnancy in …

TK Mutabingwa, K Muze, R Ord, M Briceño… - PLos one, 2009 - journals.plos.org
Background Malaria in pregnancy is serious, and drug resistance in Africa is spreading.
Drugs have greater risks in pregnancy and determining the safety and efficacy of drugs in …

In Vitro Activity of Antifolate and Polymorphism in Dihydrofolate Reductase of Plasmodium falciparum Isolates from the Kenyan Coast: Emergence of Parasites with Ile …

SM Kiara, J Okombo, V Masseno, L Mwai… - Antimicrobial agents …, 2009 - Am Soc Microbiol
We have analyzed the activities of the antifolates pyrimethamine (PM), chlorcycloguanil
(CCG), WR99210, trimethoprim (TMP), methotrexate (MTX), and trimetrexate (TMX) against …